Trial NCT01089725

View at ClinicalTrials.gov 
Org. Study IDs: A4091027
Secondary IDs: SC/IV OA STUDY

Last trial update was posted on 2021-05-05

MeSH Interventions

Tanezumab

MeSH Conditions

Osteoarthritis

Other Conditions

Arthritis Pain

Stopping Reasons

See termination reason in detailed description.

Limitations And Caveats

Due to United States Food and Drug Administration (FDA) imposed clinical hold, enrollment was stopped prematurely and, therefore, was insufficient to yield adequate power to fulfill the primary objectives.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID